Catellani C

No ORCID on file · 3 papers in corpus · active 2018-2026
2026
IGF-II, IGFBP-4, -6, and -7, and HMGB1 show changes in follicular fluid in PCOS.
Frontiers in endocrinology ·doi:10.3389/fendo.2026.1856759

IntroductionPolycystic ovary syndrome (PCOS) is a multisystem endocrine and metabolic disease characterized by chronic low-grade inflammation, ovulatory dysfunction, hyperandrogenism, and insulin resistance. Chronic inflammation modifies th…

2019
MiRNAs Regulating Insulin Sensitivity Are Dysregulated in Polycystic Ovary Syndrome (PCOS) Ovaries and Are Associated With Markers of Inflammation and Insulin Sensitivity.
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00879

Objective: MicroRNAs (miRNAs) are gene expression regulators. Altered miRNA levels are associated with diabetes, insulin resistance, and inflammation. Insulin resistance and inflammation are both features of Polycystic ovary syndrome (PCOS)…

2018
Current Knowledge on Endocrine Disrupting Chemicals (EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood: Highlights from a National Italian Meeting.
International journal of molecular sciences ·doi:10.3390/ijms19061647

Wildlife has often presented and suggested the effects of endocrine disrupting chemicals (EDCs). Animal studies have given us an important opportunity to understand the mechanisms of action of many chemicals on the endocrine system and on n…